Inclusion body myositis (IBM): clinical features
Evidence-based neurology checklist on inclusion body myositis (ibm): clinical features: Background IBM is a late-onset inflammatory myopathy It is typically acquired It may however be hereditary It has both inflammatory and degenerative components Demographic features Classical weakness pattern…
Background
- IBM is a late-onset inflammatory myopathy
- It is typically acquired
- It may however be hereditary
- It has both inflammatory and degenerative components
Demographic features
Classical weakness pattern
Other weakness features
Other features
Associated disorders
References
- Amato AA, Russell JA. Neuromuscular Disorders. McGraw Hill New York 2008 pp681-719.
- Solorzano GE, Phillips LH. Inclusion body myositis: diagnosis, pathogenesis, and treatment options. Rheum Dis Clin N Am 2011; 37:173-183.
- Dalakas MC. Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nature Clin Pract Neurol 2006; 2:437-447.
- Dabby R, Lange DJ, Trojaborg W, et al. Inclusion body myositis mimicking motor neuron disease. Arch Neurol 2001; 58:1253-1256.
- Damian L, Login CC, Solomon C, et al. Inclusion body myositis and neoplasia: a narrative review. Int J Mol Sci 2022; 23:7358.
- And 18 more. Subscribe to see the full list
